As scientists around the world race to develop a vaccine for the COVID-19 novel coronavirus, a new survey has found that less than half of American respondents would be willing to have such a vaccine administered to them.
The Associated Press reported Wednesday that a “surprisingly low” number of Americans would be willing to receive a COVID-19 vaccine, according to a poll conducted by the AP-NORC Center for Public Affairs Research.
Recently Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a scientist on the White House Coronavirus Task Force, said that there is a “good chance” that a vaccine for the novel coronavirus could be “deployable by the end of the year, by November-December.”
US President Donald Trump has also stated that a vaccine against COVID-19 could be ready for the American people by the end of 2020, and subsequent distribution of the vaccine could happen by January 2021. AP noted that the US president has set a goal of a 300 million-dose stockpile by the new year.
“The unexpected looms large, and that’s why I think for any of these vaccines, we’re going to need a large safety database to provide the reassurance.”
Researchers found that 7 in 10 Americans opposed to receiving the vaccine voiced concerns about safety.
In addition to his comments on vaccine availability, the US president has argued that COVID-19 will not have a strong second wave and could even be “eradicated” without a vaccine.
“But I think what happens is: it’s gonna go away. This is gonna go away. And whether it comes back in a modified form in the fall, we’ll be able to handle it. We’ll be able to put out spurts. And we’re very prepared to handle it,” he said late last month. However, when asked to explain his theory, Trump was unable to provide a substantive answer.
Despite US officials’ confidence in the development of a vaccine by the year’s end, experts from the World Health Organization (WHO) have warned that the global impact of the novel coronavirus may extend to 2025.
Earlier this month Soumya Swaminathan, the WHO’s chief scientist, told the Financial Times’ Global Boardroom webinar that she guesstimates a “four to five-year timeframe” would be realistic for controlling the virus.